• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Coping behavior in multiple sclerosis-complementary and alternative medicine: A cross-sectional study.多发性硬化症的应对行为——补充和替代医学:一项横断面研究。
CNS Neurosci Ther. 2018 Sep;24(9):784-789. doi: 10.1111/cns.12857. Epub 2018 Apr 10.
2
The use of complementary and alternative medicine in patients with multiple sclerosis: a longitudinal study.多发性硬化症患者中补充和替代医学的应用:一项纵向研究。
Complement Ther Med. 2014 Feb;22(1):166-72. doi: 10.1016/j.ctim.2013.11.006. Epub 2013 Nov 28.
3
Why physicians need to look more closely at the use of complementary and alternative medicine by multiple sclerosis patients.为什么医生需要更密切关注多发性硬化症患者对补充和替代医学的使用情况。
Eur J Neurol. 2004 Apr;11(4):263-7. doi: 10.1046/j.1468-1331.2003.00758.x.
4
How frequently do patients with multiple sclerosis use complementary and alternative medicine?多发性硬化症患者使用补充和替代医学的频率如何?
Complement Ther Med. 2005 Dec;13(4):258-63. doi: 10.1016/j.ctim.2005.05.006. Epub 2005 Aug 31.
5
Complementary and alternative medicine in multiple sclerosis.多发性硬化症中的补充和替代医学。
J Neurol. 2008 Dec;255 Suppl 6:82-6. doi: 10.1007/s00415-008-6015-9.
6
Frequency of current utilisation of complementary and alternative medicine by patients with multiple sclerosis.多发性硬化症患者使用补充和替代医学的当前频率。
J Neurol. 2006 Oct;253(10):1331-6. doi: 10.1007/s00415-006-0217-9. Epub 2006 Jun 19.
7
Use and users of complementary and alternative medicine among people with multiple sclerosis in Denmark.丹麦多发性硬化症患者对补充和替代医学的使用情况及使用者情况
Dan Med J. 2016 Jan;63(1):B5159.
8
Complementary and alternative medicine in multiple sclerosis: a questionnaire-based study.多发性硬化症中的补充和替代医学:基于问卷的研究。
Neurol Neurochir Pol. 2022;56(5):428-434. doi: 10.5603/PJNNS.a2022.0059. Epub 2022 Sep 7.
9
Use of complementary and alternative medicine in patients with multiple sclerosis in Germany.德国多发性硬化症患者中补充和替代医学的应用。
Complement Ther Med. 2018 Feb;36:113-117. doi: 10.1016/j.ctim.2017.12.006. Epub 2017 Dec 13.
10
Complementary and Alternative Medicine Usage by Multiple Sclerosis Patients: Results from a Prospective Clinical Study.多发性硬化症患者使用补充和替代医学的情况:一项前瞻性临床研究的结果
J Altern Complement Med. 2018 Jun;24(6):596-602. doi: 10.1089/acm.2017.0268. Epub 2018 Mar 2.

引用本文的文献

1
Importance of Coping Strategies on Quality of Life in People with Multiple Sclerosis: A Systematic Review.应对策略对多发性硬化症患者生活质量的重要性:一项系统综述。
J Clin Med. 2024 Sep 18;13(18):5505. doi: 10.3390/jcm13185505.
2
Update and Application of a Deep Learning Model for the Prediction of Interactions between Drugs Used by Patients with Multiple Sclerosis.用于预测多发性硬化症患者用药间相互作用的深度学习模型的更新与应用
Pharmaceutics. 2023 Dec 19;16(1):3. doi: 10.3390/pharmaceutics16010003.
3
Therapy of women with multiple sclerosis: an analysis of the use of drugs that may have adverse effects on the unborn child in the event of (unplanned) pregnancy.多发性硬化症女性的治疗:对在(意外)怀孕情况下可能对未出生胎儿产生不良影响的药物使用情况的分析。
Ther Adv Drug Saf. 2023 Jan 11;14:20420986221143830. doi: 10.1177/20420986221143830. eCollection 2023.
4
Conceptualization, use, and outcomes associated with compassion in the care of people with multiple sclerosis: a scoping review.概念化、使用与多发性硬化症患者关怀中同情的相关结果:范围综述。
J Neurol. 2023 Mar;270(3):1300-1322. doi: 10.1007/s00415-022-11497-x. Epub 2022 Nov 29.
5
Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases.多发性硬化症患者严重药物相互作用的筛查:三个药物相互作用数据库的比较。
Front Pharmacol. 2022 Aug 5;13:946351. doi: 10.3389/fphar.2022.946351. eCollection 2022.
6
Associated factors of potential drug-drug interactions and drug-food interactions in patients with multiple sclerosis.多发性硬化症患者潜在药物相互作用和药物-食物相互作用的相关因素。
Ther Adv Chronic Dis. 2022 Aug 4;13:20406223221108391. doi: 10.1177/20406223221108391. eCollection 2022.
7
The risk of polypharmacy, comorbidities and drug-drug interactions in women of childbearing age with multiple sclerosis.育龄期多发性硬化症女性患者多重用药、合并症及药物相互作用的风险
Ther Adv Neurol Disord. 2020 Dec 19;13:1756286420969501. doi: 10.1177/1756286420969501. eCollection 2020.

本文引用的文献

1
The burden of multiple sclerosis and patients' coping strategies.多发性硬化症的负担及患者的应对策略。
BMJ Support Palliat Care. 2018 Mar;8(1):38-40. doi: 10.1136/bmjspcare-2017-001324. Epub 2017 Jun 24.
2
Prevalence and patterns of use of mantra, mindfulness and spiritual meditation among adults in the United States.美国成年人中咒语、正念和精神冥想的使用流行情况及模式。
BMC Complement Altern Med. 2017 Jun 15;17(1):316. doi: 10.1186/s12906-017-1827-8.
3
Complementary and integrative medicine in the management of headache.头痛的补充和整合医学管理。
BMJ. 2017 May 16;357:j1805. doi: 10.1136/bmj.j1805.
4
Complementary and Alternative Medicine Use and Its Association with Emotional Status and Quality of Life in Patients with a Solid Tumor: A Cross-Sectional Study.实体瘤患者补充与替代医学的使用及其与情绪状态和生活质量的关联:一项横断面研究
J Altern Complement Med. 2017 May;23(5):362-369. doi: 10.1089/acm.2016.0289. Epub 2017 Apr 28.
5
Social cognition in multiple sclerosis: A systematic review and meta-analysis.多发性硬化症中的社会认知:系统评价与荟萃分析。
Neurology. 2016 Oct 18;87(16):1727-1736. doi: 10.1212/WNL.0000000000003236. Epub 2016 Sep 21.
6
Coping with multiple sclerosis-the role of social support.应对多发性硬化症——社会支持的作用
Acta Neurol Scand. 2017 Jul;136(1):11-16. doi: 10.1111/ane.12673. Epub 2016 Sep 12.
7
Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registry.多发性硬化症的对症治疗——一项全国性登记研究的中期分析
Acta Neurol Scand. 2017 Apr;135(4):394-399. doi: 10.1111/ane.12612. Epub 2016 Jun 9.
8
The experiences of persons living with HIV who participate in mind-body and energy therapies: a systematic review protocol of qualitative evidence.参与身心与能量疗法的艾滋病病毒感染者的经历:定性证据的系统评价方案
JBI Database System Rev Implement Rep. 2015 Oct;13(10):41-9. doi: 10.11124/jbisrir-2015-2321.
9
Cancer patients taking herbal medicines: A review of clinical purposes, associated factors, and perceptions of benefit or harm.服用草药的癌症患者:临床目的、相关因素及对益处或危害的认知综述
J Ethnopharmacol. 2015 Dec 4;175:58-66. doi: 10.1016/j.jep.2015.08.052. Epub 2015 Sep 3.
10
Patients characteristics influencing the longitudinal utilization of steroids in multiple sclerosis--an observational study.影响多发性硬化症患者长期使用类固醇的因素——一项观察性研究。
Eur J Clin Invest. 2015 Jun;45(6):587-93. doi: 10.1111/eci.12450. Epub 2015 May 9.

多发性硬化症的应对行为——补充和替代医学:一项横断面研究。

Coping behavior in multiple sclerosis-complementary and alternative medicine: A cross-sectional study.

机构信息

Department of Neurology, Neuroimmunological Section, University of Rostock, Rostock, Germany.

Department of Neurology, Medical University of Vienna, Vienna, Austria.

出版信息

CNS Neurosci Ther. 2018 Sep;24(9):784-789. doi: 10.1111/cns.12857. Epub 2018 Apr 10.

DOI:10.1111/cns.12857
PMID:29635832
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6120478/
Abstract

MAIN PROBLEM

Treatment options for multiple sclerosis (MS) have enlarged tremendously over the last years. Nonetheless, lots of patients look for alternative treatment options. The use of complementary and alternative medicine (CAM) is widespread in MS, however, its scientific investigation is limited so far. The aim of the study is to analyse clinical and demographical differences of MS patients in dependency of their CAM utilization as coping strategy.

METHODS

A total of 254 patients with a clinically definite MS were examined in a semistructured interview. Additional standardized questionnaires were used to measure different aspects of coping with illness. All patients underwent neurological examination.

RESULTS

About 206 of all enrolled patients are CAM users (81.1%). They have a longer disease duration (8.3 years vs 7.3 years, P = 0.028) and show higher disability (median EDSS 4.0 vs 2.0, P < 0.001) than nonusers. CAM users differed significantly from nonusers in their coping behavior (P = 0.035). Users are brooding more heavily over the disease, looking for more information about MS, and are looking for a sense of their disease in religion more often than nonusers. CAM users are at a higher risk of depression. Almost two-thirds of CAM users (57.6%) reported positive effects on the well-being of their state of health.

CONCLUSION

Coping behavior differs significantly between CAM users and nonusers. CAM utilization is associated with higher disability and depression. More than 80% of our cohort has used alternative or complementary methods. CAM utilization may mirror unmet needs in the treatment of MS.

摘要

主要问题

近年来,多发性硬化症(MS)的治疗选择大大增加。尽管如此,许多患者仍在寻找替代治疗方案。在 MS 中,补充和替代医学(CAM)的应用非常广泛,但迄今为止,其科学研究仍很有限。本研究的目的是分析 MS 患者在使用 CAM 作为应对策略时的临床和人口统计学差异。

方法

在半结构化访谈中对 254 名经临床确诊的 MS 患者进行了检查。使用额外的标准化问卷来测量不同方面的疾病应对情况。所有患者均接受了神经系统检查。

结果

所有入组患者中约有 206 名(81.1%)是 CAM 用户。他们的疾病病程更长(8.3 年 vs 7.3 年,P=0.028),残疾程度更高(中位数 EDSS 4.0 vs 2.0,P<0.001)。CAM 用户与非用户在应对行为上存在显著差异(P=0.035)。使用者对疾病的担忧更严重,更频繁地寻找有关 MS 的信息,并且更频繁地从宗教中寻找疾病的意义。CAM 用户患抑郁症的风险更高。近三分之二的 CAM 用户(57.6%)报告称,CAM 对他们的健康状况和幸福感有积极影响。

结论

CAM 用户和非用户的应对行为存在显著差异。CAM 的应用与更高的残疾和抑郁风险相关。我们队列中的超过 80%的患者已经使用了替代或补充方法。CAM 的应用可能反映了 MS 治疗中未满足的需求。